Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-08-14Clinical Trial Update: An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University Hospital
A completed clinical study analyzing factors that influence the management costs for adults with inflammatory bowel disease treated with bio…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease [Phase 4]
Phase 4 clinical trial evaluating azithromycin-based therapy to induce remission in active pediatric Crohn's disease; the study is completed…
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Long Term Observational Study of a Vagal Nerve Stimulation Device in Crohn's Disease [Phase 1, Phase 2]
A long-term observational study of a vagal nerve stimulation device for Crohn's disease is being conducted. The current status of the study …
-
CLINICAL_TRIALS research · 2017-08-03Clinical Trial Update: Vagus Nerve Stimulation in Crohn's Disease [NA]
A clinical trial update describes a study evaluating vagus nerve stimulation for Crohn's disease conducted by SetPoint Medical, with the cur…
-
FDA approval · 2017-07-31FDA Approved: BUDESONIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's original application for budesonide (generic). Budesonide is a corticosteroid used to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-07-27FDA Approved: MESALAMINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for mesalamine filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2017-07-27FDA Approved: MESALAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Mesalamine from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects [Phase 1]
Phase 1 study to assess the effect of GSK1605786 on hepatic cytochrome P450 enzymes and BCRP and OATP1B1 transport in healthy adults; study …
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Individualized Infiximab Dosing-Proof of Concept Study
A clinical trial update for a proof-of-concept study on individualized dosing of infliximab in inflammatory bowel diseases. The sponsor is C…
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
This update covers a clinical trial examining whether small bowel ultrasound can inform the initiation of infliximab therapy in Crohn's dise…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Self-Management Assistance for Recommended Treatment (SMART) Portal
The SMART Portal clinical trial, sponsored by Cincinnati Children's Hospital Medical Center, has completed and evaluated a self-management p…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease [Phase 3]
Phase 3 trial update evaluating rifaximin to prevent postoperative recurrence in Crohn's disease; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: CAre of Patients With PArenteral Nutrition At Home
Completed clinical trial update from KU Leuven on management of patients receiving parenteral nutrition at home.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects [Phase 1]
A Phase 1 study in healthy subjects compared the relative bioavailability of four new formulations of GSK1605786; the trial status is comple…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 [Phase 1]
This first-in-human Phase 1 trial evaluates the safety, tolerability, and pharmacokinetics of GSK1399686 in inflammatory bowel diseases and …
-
CLINICAL_TRIALS withdrawal · 2017-07-06Clinical Trial Update: Phase 1 Crohn's Pediatric Sub-study of MSC AFP [Phase 1]
Phase 1 Crohn's disease pediatric sub-study of MSC AFP for perianal fistula has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease [Phase 2]
Phase 2 trial update evaluating the immunological and hematological effects of STA-5326 Mesylate in patients with Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: G-CSF to Treat Crohn's Disease [Phase 1]
A Phase 1 clinical trial evaluating granulocyte colony-stimulating factor (G-CSF) for Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Trichuris suis ova (TSO) versus placebo in Crohn's disease; results have been posted.
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis [Phase 1]
Clinical trial update comparing biodegradable stenting anastomoses to double-layer hand sutures for reconstruction in intestinal anastomosis…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease
A completed AbbVie-sponsored clinical trial assessed the impact of Anti-TNF therapies on work productivity and quality of life in Crohn's di…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease [Phase 3]
A Phase 3 study evaluating rifaximin combined with a thiopurine to prevent postoperative recurrence in Crohn's disease. The study status is …
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Japanese Phase I of GSK1605786 [Phase 1]
The Japanese Phase I trial of GSK1605786 for Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2017-06-08Clinical Trial Update: Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease [NA]
A trial update evaluating partial versus exclusive enteral nutrition in active childhood-onset Crohn's disease; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects [Phase 1]
A completed Phase 1 pharmacokinetic study of the investigative compound GSK1605786 in healthy Chinese subjects, with Crohn's disease listed …